呼吸系統(tǒng)疾病在國(guó)內(nèi)外均為一種常見(jiàn)疾病，近年來(lái)由于環(huán)境等問(wèn)題，發(fā)病率逐年上升，因此呼吸系統(tǒng)用藥市場(chǎng)龐大，具有較大的發(fā)展前景。對(duì)國(guó)內(nèi)外呼吸系統(tǒng)藥品研發(fā)現(xiàn)狀進(jìn)行簡(jiǎn)述，并重點(diǎn)介紹了哮喘和慢性阻塞性肺部疾?。╟hronic obstructive pulmonary disease，COPD）兩大研究領(lǐng)域的新藥研發(fā)情況，以期為相關(guān)研發(fā)人員提供參考。

Respiratory disease is very common in the world. In recent years, because of air pollution, the incidence of respiratory disease is rising year by year, so the market of medicine used for the treatment of respiratory disease is huge and has large development space. This article is an overview and summary on the development of respiratory system drugs at home and abroad, which highlights the major respiratory indications like asthma and chronic obstructive pulmonary disease and would provide a reference for the related researchers.